JOHN CHANCELLOR

Concepts (11)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glucagon-Like Peptides
1
2024
33
0.970
Why?
Glucagon-Like Peptide-1 Receptor
1
2024
74
0.920
Why?
Retinitis Pigmentosa
1
2024
85
0.910
Why?
Diabetic Retinopathy
1
2024
161
0.800
Why?
Hypoglycemic Agents
1
2024
599
0.710
Why?
Genetic Therapy
1
2024
1716
0.560
Why?
Optogenetics
1
2024
54
0.240
Why?
Neuroprotective Agents
1
2024
220
0.210
Why?
Cell- and Tissue-Based Therapy
1
2024
383
0.200
Why?
Diabetes Mellitus, Type 2
1
2024
1412
0.120
Why?
Humans
2
2024
270740
0.040
Why?
CHANCELLOR's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (11)
Explore
_
Co-Authors (2)
Explore
_
Same Department Expand Description
Explore
_